Arix Bioscience PLC | Finanzwire

PRESS RELEASE

published on 07/17/2023 at 16:00, 2 years 8 months ago

Holding(s) in Company
PRESS RELEASE

published on 07/13/2023 at 08:01, 2 years 8 months ago

Arix Announces Strategic Review
PRESS RELEASE

published on 07/13/2023 at 08:00, 2 years 8 months ago

Unaudited NAV for June 2023
PRESS RELEASE

published on 06/23/2023 at 15:03, 2 years 9 months ago

Portfolio company Disc Medicine raises $157.8 million in public offering
PRESS RELEASE

published on 06/09/2023 at 15:53, 2 years 9 months ago

Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
PRESS RELEASE

published on 06/09/2023 at 08:00, 2 years 9 months ago

Unaudited NAV for May 2023
PRESS RELEASE

published on 05/24/2023 at 08:00, 2 years 10 months ago

Correction: Result of Annual General Meeting
PRESS RELEASE

published on 05/23/2023 at 17:30, 2 years 10 months ago

Result of Annual General Meeting
PRESS RELEASE

published on 05/16/2023 at 17:36, 2 years 10 months ago

Portfolio company Ensoma announces closing of Series B Extension
PRESS RELEASE

published on 05/12/2023 at 08:00, 2 years 10 months ago

Unaudited NAV for April 2023

Published on 03/25/2026 at 18:53, 2 hours 48 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 3 hours 10 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 3 hours 56 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 3 hours 56 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS
Published on 03/25/2026 at 17:42, 3 hours 59 minutes ago

2025/2026 Second quarter Sales

News